News

Article July 23, 2026

Heart Disease Genetic Risk: New Study Reveals Why Populations Differ

For decades, a DNA-based test for cardiovascular disease seemed to work for Europeans and others but not Africans. Gladstone scientists just discovered why, with implications for many other diseases.

Human Genetics Data Science and Biotechnology Tcheandjieu Lab News Release Research (Publication)

Article July 23, 2026

Misfolded DNA Blueprint: A New Origin for Genetic Disease

Gladstone researchers found losing just one copy a particular gene can disrupt heart development and lead to congenital heart disease.

News Release Bruneau Lab Pollard Lab Cardiovascular Disease Data Science and Biotechnology Congenital Heart Disease Stem Cells/iPSCs

Article July 17, 2026

Gladstone Scientists Are Awarded $2 Million to Map How HIV Affects the Immune System

By uniting the power of single-cell sequencing, organoids, and artificial intelligence, scientists are entering a new era of HIV research.

Roan Lab Ott Lab Grants HIV/AIDS Organoids AI

Article July 14, 2026

An Ancient Genetic Twist and Its Modern Impact on Brain Disease

NOMIS–Gladstone Fellow Cathrine Sant is studying an enigmatic region of the human genome linked to neurodegenerative disease risk.

Neurological Disease NOMIS Graduate Students and Postdocs Profile

Article July 8, 2026

Controlling Oxygen to Fight Disease

New research shows low oxygen can help alleviate disease caused by defects in a mitochondrial quality control machinery.

News Release Research (Publication) Jain Lab Metabolism

Article July 6, 2026

Gladstone Institutes Receives National Recognition for Excellence in Postdoc Programs

Gladstone is one of only 12 institutions nationwide to receive the award for its postdoctoral programs.

News Release Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Postdoc Advisory Committee Awards

Article July 1, 2026

Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke

Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.

Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News Release

Article June 23, 2026

Meet Gladstone: Kevin Pastores

Kevin Pastores, assistant core director of Gladstone’s Flow Cytometry Core, helps researchers across disciplines design experiments, analyze complex cellular data, and harness emerging technologies like AI to accelerate discovery.

Profile Flow Cytometry Core

Article June 17, 2026

Christina Theodoris Honored in Inaugural Cohort of Young American Scientists

Scientific American recognizes Theodoris for her pioneering work developing artificial intelligence models to find treatments for an array of diseases.

Theodoris Lab AI Data Science and Biotechnology Cardiovascular Disease Awards News Release

Article June 16, 2026

Magnus Hoffmann Honored as 2026 Pew Biomedical Scholar

The Gladstone scientist, an expert in vaccine development, is recognized for his pioneering approach to advancing human health and medicine.

Infectious Disease Awards

Article June 9, 2026

How an AI Microscope Is Learning to Do Science

Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.

Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s Disease

Video June 9, 2026

This Is AI Designing Its Own Experiments

Gladstone scientists have developed a thinking microscope powered by artificial intelligence.

AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALS

Article June 8, 2026

New CRISPR Technique Selectively Shreds Cancer Cells, Including Those of ‘Undruggable’ Cancers

An innovative chromatin-shredding technique shown to destroy cancer cells carrying a prevalent mutation while keeping healthy cells intact.

News Release Research (Publication) Doudna Lab CRISPR/Gene Editing Cancer

Article June 2, 2026

Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections

The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.

News Release Grants Data Science and Biotechnology Infectious Disease Shipman Lab Pollard Lab Ott Lab Silas Lab AI

Article June 1, 2026

Gladstone Investigator Andrew Yang Receives 2026 Sobrato Prize in Neuroscience

The prize honors scientists whose breakthroughs in brain research have high potential for patient impact.

Philanthropy Awards News Release Alzheimer’s Disease Neurological Disease Yang Lab